These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21556801)

  • 1. A prospective clinical trial of lenalidomide with topotecan in women with advanced epithelial ovarian carcinoma.
    Carter JS; Downs LS
    Int J Clin Oncol; 2011 Dec; 16(6):666-70. PubMed ID: 21556801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma.
    Selle F; Sevin E; Ray-Coquard I; Mari V; Berton-Rigaud D; Favier L; Fabbro M; Lesoin A; Lortholary A; Pujade-Lauraine E
    Ann Oncol; 2014 Nov; 25(11):2191-2196. PubMed ID: 25210017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma.
    Downs LS; Judson PL; Argenta PA; Ghebre R; Geller MA; Bliss RL; Boente MP; Nahhas WA; Abu-Ghazaleh SZ; Chen MD; Carson LF
    Cancer; 2008 Jan; 112(2):331-9. PubMed ID: 18058810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weekly topotecan and daily thalidomide in patients with recurrent epithelial ovarian cancer: a report of 2 cases.
    Phippen NT; Leath CA
    J Reprod Med; 2009 Sep; 54(9):583-6. PubMed ID: 19947038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I study of weekly topotecan and Paclitaxel in previously treated epithelial ovarian carcinoma patients.
    Homesley H; Benigno B; Williams J; Vaccarello L
    Gynecol Oncol; 2002 Nov; 87(2):171-7. PubMed ID: 12477447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II clinical trial of topotecan and carboplatin in patients with newly diagnosed advanced epithelial ovarian cancer.
    Vecchione F; Fruscio R; Dell'Anna T; Garbi A; Garcia Parra R; Corso S; Lissoni AA
    Int J Gynecol Cancer; 2007; 17(2):367-72. PubMed ID: 17362314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study of alternating doublets of topotecan/carboplatin and paclitaxel/carboplatin in patients with newly diagnosed, advanced ovarian cancer.
    Gordon AN; Hancock KC; Matthews CM; Messing M; Stringer CA; Doherty MG; Teneriello M
    Gynecol Oncol; 2002 Apr; 85(1):129-35. PubMed ID: 11925132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy.
    Sehouli J; Stengel D; Oskay G; Camara O; Hindenburg HJ; Klare P; Blohmer J; Heinrich G; Elling D; Ledwon P; Lichtenegger W;
    Ann Oncol; 2002 Nov; 13(11):1749-55. PubMed ID: 12419747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suvemcitug plus chemotherapy for platinum-resistant epithelial ovarian, fallopian tube and primary peritoneal cancer: A phase 1b dose-escalation trial.
    Yuan G; Zhang K; Zheng H; Wu Y; Sun H; Zhang J; Sun X; Wu L
    Gynecol Oncol; 2024 Aug; 187():212-220. PubMed ID: 38805876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane. Results from a multicenter phase I/II study.
    Gronlund B; Engelholm SA; Horvath G; Mäenpää J; Ridderheim M
    Cancer; 2005 Apr; 103(7):1388-96. PubMed ID: 15719439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topotecan in platinum- and paclitaxel-resistant ovarian cancer.
    Swisher EM; Mutch DG; Rader JS; Elbendary A; Herzog TJ
    Gynecol Oncol; 1997 Sep; 66(3):480-6. PubMed ID: 9299264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I dose-escalation study of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer.
    Ullenhag GJ; Rossmann E; Liljefors M
    PLoS One; 2015; 10(4):e0121197. PubMed ID: 25837499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study.
    Stathopoulos GP; Rigatos SK; Christodoulou C; Malamos NA; Deliyiannis F; Stathopoulos JG; Skarlos DV
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):259-64. PubMed ID: 15127231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
    Miller AA; Hargis JB; Lilenbaum RC; Fields SZ; Rosner GL; Schilsky RL
    J Clin Oncol; 1994 Dec; 12(12):2743-50. PubMed ID: 7527456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low-dose topotecan in second-line treatment for patients with epithelial ovarian carcinoma.
    Gronlund B; Hansen HH; Høgdall C; Engelholm SA
    Cancer; 2002 Oct; 95(8):1656-62. PubMed ID: 12365013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II study of topotecan in combination with carboplatin in recurrent epithelial ovarian cancer.
    Bolis G; Scarfone G; Sciatta C; Polverino GP; Rosa C; Guarnerio P; Parazzini F
    Gynecol Oncol; 2001 Dec; 83(3):477-80. PubMed ID: 11733958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Topotecan: prospects for using it in combination therapy for ovarian carcinoma].
    Scarfone G
    Tumori; 1999; 85(6 Suppl 1):S12-5. PubMed ID: 10786195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of weekly topotecan in the treatment of heavily pretreated recurrent epithelial ovarian and primary peritoneal cancer: the Kaohsiung Chang Gung experience.
    Hu CF; Ou YC; Fu HC; Chang Chien CC; Tsai CC; Wu CH; Lin H
    Taiwan J Obstet Gynecol; 2015 Feb; 54(1):43-7. PubMed ID: 25675918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors.
    Penson RT; Supko JG; Seiden MV; Fuller AF; Berkowitz RS; Goodman A; Campos SM; MacNeill KM; Cook S; Matulonis UA
    Cancer; 2001 Sep; 92(5):1156-67. PubMed ID: 11571729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer.
    Stein SM; Tiersten A; Hochster HS; Blank SV; Pothuri B; Curtin J; Shapira I; Levinson B; Ivy P; Joseph B; Guddati AK; Muggia F
    Int J Gynecol Cancer; 2013 Nov; 23(9):1577-82. PubMed ID: 24172094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.